References
Gagniere J, Veziant J, Pereira B, Pezet D, Le Roy B, Slim K. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the elderly: is it reasonable? A meta-analysis. Ann Surg Oncol. 2018;25:709–19.
Fagard K, Leonard S, Deschodt M, et al. The impact of frailty on postoperative outcomes in individuals aged 65 and over undergoing elective surgery for colorectal cancer: a systematic review. J Geriatr Oncol. 2016;7:479–91.
Robinson TN, Eiseman B, Wallace JI, et al. Redefining geriatric preoperative assessment using frailty, disability and comorbidity. Ann Surg. 2009;250:449–55.
Alyami M, Lundberg P, Kepenekian V, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly: a case-controlled, multicenter study. Ann Surg Oncol. 2016;23:737–45.
Votanopoulos KI, Newman NA, Russell G, et al. Outcomes of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality. Ann Surg Oncol. 2013;20:3497–503.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
There are no conflicts of interest.
Additional information
ASO Author Reflections offer a brief invited commentary on the article, Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Elderly: Is It Reasonable? A Meta-Analysis. Ann Surg Oncol. 2018;25:709–19.
Rights and permissions
About this article
Cite this article
Gagnière, J. HIPEC in the Elderly: A Meta-Analysis. Ann Surg Oncol 25 (Suppl 3), 701–702 (2018). https://doi.org/10.1245/s10434-018-6776-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-018-6776-z